About us
Our company is founded on a passion for pioneering advancements in vaccine development.
Our Mission
We develop innovative vaccines for a healthier world.
Our Vision
We want to transform healthcare by developing novel vaccines that are lifesaving and improving quality of life around the world.
Our Approach
We leverage our proprietary ExpreS2 protein expression system, employing insect cells to synthesize proteins essential for vaccine development. Our methodology involves prudent selection of pertinent antigens, engineering of the antigens for optimal expression in the ExpreS2 system, and rigorous implementation of quality control protocols.
Our strategy is geared towards accelerating the development of drug candidates with short timelines and cost-effective paths to value creation.
Team
Our team has more than 100 years of experience relevant to drug development and is committed to developing innovative vaccines for the world’s worst infectious diseases and cancer, channeling their expertise and passion into pioneering advancements.
Executive Management
Bent U. Frandsen
Chief Executive Officer
Keith Alexander
Chief Financial Officer
Dr. Farshad Guirakhoo
Chief Scientific Officer
Dr. Max M. Søgaard
Senior Vice President of R&D and Technology
Board of Directors
Dr. Martin Roland Jensen
Chairman
Dr. Karin Garre
Board Member
Jakob Knudsen
Board Member
Sara Sande
Board Member
Advisory Boards
ExpreS2ion Biotechnologies boasts two distinguished scientific advisory boards: the Oncology Scientific Advisory Board and the Infectious Diseases Scientific Advisory Board.
These expert panels contribute invaluable insights, guiding the company’s research and development efforts in cancer and infectious disease vaccines, respectively. Their collective expertise enhances ExpreS2ion’s strategic decision-making and supports cutting-edge advancements in these critical fields.
Advisory Board - Infectious Diseases
Dr. Stanley Plotkin
MD, PhD, DMSci
Dr. Allan Randrup Thomsen
MD, DMSci
Dr. Lone Graff Stensballe
MD, PhD, DMSci
Dr. Mark Schleiss
MD
Advisory Board - Oncology
Dr. Giuseppe Curigliano
MD, PhD
Dr. Javier Cortes
MD, PhD
Dr. Ulrik Lassen
MD, PhD
Dr. Michael Andersson
MD, DMSci
Dr. Rupert Bartsch
MD
Dr. Daniel Lenihan
MD, FACC, FESC, FIC-OS
